Bristol-Myers Squibb Profit Margin 2006-2018 | BMY
Current and historical gross margin, operating margin and net profit margin for Bristol-Myers Squibb (BMY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bristol-Myers Squibb net profit margin as of September 30, 2018 is 6.5%.
|Bristol-Myers Squibb Annual Profit Margins
|Bristol-Myers Squibb Quarterly Profit Margins
||Large Cap Pharmaceutical
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.